Nadine van Montfoort

9PUBLICATIONS
35CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 09, 2024
Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell-Based Immunotherapies.

Christianne Groeneveldt, Priscilla Kinderman, Lisa Griffioen

|Nov 08, 2023
Unraveling the impact of sialic acids on the immune landscape and immunotherapy efficacy in pancreatic cancer.

Kelly Boelaars, Laura Goossens-Kruijssen, Di Wang

|May 27, 2023
The Tango between Cancer-Associated Fibroblasts (CAFs) and Immune Cells in Affecting Immunotherapy Efficacy in Pancreatic Cancer.

Imke Stouten, Nadine van Montfoort, Lukas J A C Hawinkels

|Mar 02, 2023
Intertumoral Differences Dictate the Outcome of TGF-β Blockade on the Efficacy of Viro-Immunotherapy.

Christianne Groeneveldt, Jurriaan Q van Ginkel, Priscilla Kinderman

|Jul 19, 2022
Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapy.

Christianne Groeneveldt, Priscilla Kinderman, Jordi J C van Stigt Thans

Pageof 2